thus , it is unlikely that the mechanism of the cardiac toxicity produced by mitoxantrone and m-amsa in patients previously treated with anthracycline drugs can be directly related to oxidation-reduction cycling catalyzed by cardiac flavin dehydrogenases .
C0030012
oxidation-reduction
C0030016
dehydrogenases